REGULUS THERAPEUTICS INC (RGLS) Stock Balance Sheet
NASDAQ:RGLS - Nasdaq - US75915K3095 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 38.53M | 23.77M | 24.23M | 60.38M | 31.09M | |||
| Marketable Securities | 37.25M | 0.00 | 14.93M | N/A | N/A | |||
| Receivables | N/A | N/A | N/A | 0.00 | 503.00K | |||
| Other Current Assets | 6.57M | 4.41M | 4.92M | 4.85M | 5.14M | |||
| Total Current Assets | 82.34M | 28.18M | 44.08M | 65.23M | 36.73M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.81M | 2.54M | 2.58M | 2.85M | 472.00K | |||
| Intangibles | 25.00K | 33.00K | 62.00K | 83.00K | 125.00K | |||
| Other Non-Current Assets | N/A | N/A | 0.00 | 291.00K | 277.00K | |||
| Total Non-Current Assets | 1.84M | 2.57M | 2.64M | 3.22M | 874.00K | |||
| TOTAL ASSETS | 84.18M | 30.75M | 46.72M | 68.45M | 37.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 0.00 | 1.33M | 4.51M | 0.00 | 4.65M | |||
| Accrued Expenses | 5.40M | 4.59M | 4.42M | 3.65M | 3.42M | |||
| Accounts Payable | 947.00K | 204.00K | 175.00K | 285.00K | 535.00K | |||
| Other Current Liabilities | 1.15M | 2.38M | 2.55M | 1.29M | 2.97M | |||
| Total Current Liabilities | 7.50M | 8.51M | 11.66M | 5.23M | 11.58M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 4.67M | 0.00 | |||
| Other Non-Current Liabilities | 274.00K | 1.05M | 1.77M | 3.60M | 0.00 | |||
| Total Non-Current Liabilities | 274.00K | 1.05M | 1.77M | 8.27M | 0.00 | |||
| TOTAL LIABILITIES | 7.77M | 9.56M | 13.43M | 13.50M | 11.58M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -559.57M | -513.21M | -483.18M | -454.85M | -427.05M | |||
| Additional Paid In Capital | 635.86M | 534.38M | 516.46M | 509.66M | 453.00M | |||
| Common Shares | 71.00K | 25.00K | 22.00K | 151.00K | 69.00K | |||
| Other Shareholders' Equity | 50.00K | 0.00 | -12.00K | N/A | N/A | |||
| Shares Outstanding | 65.50M | 20.22M | 16.84M | 14.60M | 6.74M | |||
| Tangible Book Value per Share | 1.17 | 1.05 | 1.97 | 3.76 | 3.84 | |||
| Total Shareholders' Equity | 76.41M | 21.19M | 33.29M | 54.96M | 26.03M | |||
| TOTAL LIABILITIES AND EQUITY | 84.18M | 30.75M | 46.72M | 68.45M | 37.60M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.09 | N/A | |||
| Current Ratio | 10.98 | 3.31 | 3.78 | 12.48 | 3.17 | |||
| Return On Assets (ROA) | -55.07% | -97.68% | -60.63% | -40.62% | -41.83% | |||
| Return On Equity (ROE) | -60.67% | -141.77% | -85.08% | -50.60% | -60.44% | |||
All data in USD , ROIC based on taxRate of 0.21